PROTEOLYTIC PROCESSING MECHANISMS OF A MINIPRECURSOR OF THE ASPARTIC PROTEASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:25
作者
CO, E
KOELSCH, G
LIN, YZ
IDO, E
HARTSUCK, JA
TANG, J
机构
[1] OKLAHOMA MED RES FDN, PROT STUDIES PROGRAM, OKLAHOMA CITY, OK 73104 USA
[2] UNIV OKLAHOMA, HLTH SCI CTR, DEPT PEDIAT, OKLAHOMA CITY, OK 73104 USA
[3] UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CITY, OK 73104 USA
关键词
D O I
10.1021/bi00171a027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The infectivity of the human immunodeficiency virus (HIV) depends upon correct proteolytic processing of viral polyprotein precursors, the pr55(gag) and Pr160(gag-pol) polyproteins. The processing is mediated spontaneously by the viral protease unit (PR) contained within the Pr160(gag-pol) precursor. However, little is known about the mechanism of this process. The expression in Escherichia coli and the isolation of a 14-kDa HIV-1 PR ''miniprecursor'' with Ala(28) mutated to serine has permitted study of the mechanism for cleavage at the N-terminus of the protease. The miniprecursor is active against a synthetic peptide substrate, and its specific activity is near that of the mutant mature protease. The rate of conversion of radiolabeled precursor to mature protease is quantitated by measuring the amounts of the two radiolabeled proteins separated by SDS-PAGE. The apparent first-order conversion rate constant, k(app,) is dependent on miniprecursor concentration indicating a second-order reaction and suggesting an interdimeric processing mechanism. A significant first-order rate constant is observed when the plot of k(app) versus initial precursor concentration is extrapolated to zero. This observation suggests the presence of an alternative processing mechanism involving a single active precursor dimer. The presence of both mechanisms is an advantage for the virus to ensure processing under various conditions.
引用
收藏
页码:1248 / 1254
页数:7
相关论文
共 43 条
[1]  
ALJANABI J, 1972, J BIOL CHEM, V247, P4628
[2]   INHIBITION OF HIV PROTEASE ACTIVITY BY HETERODIMER FORMATION [J].
BABE, LM ;
PICHUANTES, S ;
CRAIK, CS .
BIOCHEMISTRY, 1991, 30 (01) :106-111
[3]   AMINO-ACIDS ENCODED DOWNSTREAM OF GAG ARE NOT REQUIRED BY ROUS-SARCOMA VIRUS PROTEASE DURING GAG-MEDIATED ASSEMBLY [J].
BENNETT, RP ;
RHEE, S ;
CRAVEN, RC ;
HUNTER, E ;
WILLS, JW .
JOURNAL OF VIROLOGY, 1991, 65 (01) :272-280
[4]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[5]   HUMAN IMMUNODEFICIENCY VIRAL PROTEASE IS CATALYTICALLY ACTIVE AS A FUSION PROTEIN - CHARACTERIZATION OF THE FUSION AND NATIVE ENZYMES PRODUCED IN ESCHERICHIA-COLI [J].
BOUTELJE, J ;
KARLSTROM, AR ;
HARTMANIS, MGN ;
HOLMGREN, E ;
SJOGREN, A ;
LEVINE, RL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 283 (01) :141-149
[6]  
BUSTIN M, 1971, J BIOL CHEM, V246, P615
[7]   STABILITY AND ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - COMPARISON OF THE NATURAL DIMER WITH A HOMOLOGOUS, SINGLE-CHAIN TETHERED DIMER [J].
CHENG, YSE ;
YIN, FH ;
FOUNDLING, S ;
BLOMSTROM, D ;
KETTNER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9660-9664
[8]  
DARKE PL, 1989, J BIOL CHEM, V264, P2307
[9]   HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI EXHIBITS AUTOPROCESSING AND SPECIFIC MATURATION OF THE GAG PRECURSOR [J].
DEBOUCK, C ;
GORNIAK, JG ;
STRICKLER, JE ;
MEEK, TD ;
METCALF, BW ;
ROSENBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :8903-8906
[10]  
DIIANNI CL, 1990, J BIOL CHEM, V265, P17348